Literature DB >> 6818069

Insulin resistance in diabetic ketoacidosis.

E J Barrett, R A DeFronzo, S Bevilacqua, E Ferrannini.   

Abstract

The effect of "low-dose" (6--10 U/h) insulin treatment on the rate of decline of plasma glucose concentration was determined in 15 diabetic subjects admitted in ketoacidosis (plasma glucose = 948 79 mg/dl) and in six normal volunteers rendered hyperglycemic by a combined infusion of somatostatin and glucose (plasma glucose = 653 28 mg/dl). The fractional glucose turnover and the half-time of the fall in plasma glucose during insulin treatment were both 10-fold reduced (P less than 0.001) in the diabetics as compared with the controls. In the ketoacidotic subjects, the mean glucose clearance during insulin treatment was only 8% of that in the controls (P less than 0.001). In the normal subjects, tissue glucose clearance during insulin treatment of the hyperglycemia (5.8 0.7 ml/min . kg) was similar to that measured in the same subjects using a standard technique to quantitate insulin sensitivity (euglycemic insulin clamp). In the ketoacidotic patients, a history of prior insulin therapy, but not the degree of hyperglycemia at the time of admission, was associated with a more rapid rate of decline of plasma glucose in response to insulin treatment. We conclude that marked insulin resistance is present in virtually all diabetics in ketoacidosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818069     DOI: 10.2337/diab.31.10.923

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

Review 1.  Autophagy in the brains of young patients with poorly controlled T1DM and fatal diabetic ketoacidosis.

Authors:  William H Hoffman; John J Shacka; Anuska V Andjelkovic
Journal:  Exp Mol Pathol       Date:  2011-11-06       Impact factor: 3.362

2.  Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.

Authors:  William H Hoffman; Sandra L Siedlak; Yang Wang; Rudy J Castellani; Mark A Smith
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

3.  Severe ketoacidosis as the first manifestation of diabetes mellitus after age fifty.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1986-02       Impact factor: 1.798

Review 4.  The metabolic clearance of glucose: measurement and meaning.

Authors:  J Radziuk; H L Lickley
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

5.  Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes.

Authors:  Mads V Svart; Nikolaj Rittig; Ulla Kampmann; Thomas S Voss; Niels Møller; Niels Jessen
Journal:  Diabetologia       Date:  2017-04-07       Impact factor: 10.122

6.  Remission from insulin dependence induced by continuous subcutaneous insulin infusion (CSII) in type I, newly diagnosed diabetics: role of some hormonal and immunologic factors.

Authors:  G M Nardelli; E Guastamacchia; S Di Paolo; V Lattanzi; A Ciampolillo; P Montedoro; R Giorgino
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

Review 7.  Hyperglycemic crises in adult patients with diabetes.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; John M Miles; Joseph N Fisher
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

8.  Characterization of the insulin-antagonistic effect of growth hormone in man.

Authors:  J Fowelin; S Attvall; H von Schenck; U Smith; I Lager
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

9.  Normal insulin sensitivity during the phase of glucose intolerance but insulin resistance at the onset of diabetes in the spontaneously diabetic BB rat.

Authors:  M A Baudon; P Ferré; L Pénicaud; P Maulard; A Ktorza; L Castano; J Girard
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

10.  Perioperative diagnosis of euglycaemic ketoacidosis.

Authors:  Chia Yeow; Frederick Wilson; Edward Walter; Javed Sultan
Journal:  J Intensive Care Soc       Date:  2015-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.